INSIGHTS ON CLINICAL TRIAL DESIGN
-
How Sample Issues Can Cause Bioequivalence Studies To Fail
In this webinar excerpt, we learn why biological sample issues can have such an outsized impact in bioequivalence studies.
-
Why Early RTSM Involvement Matters
Early stakeholder involvement helps spot protocol and logistical misalignments before they become operational issues, strengthening RTSM readiness and reducing activation delays.
-
From Protocol Design To Actual Patients In Studies
Explore how clinical trial success increasingly depends on aligning recruitment strategies with protocol complexity through data-driven insights and tailored engagement approaches.
-
Defining And Implementing The Right Oncology Digital Strategy
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
-
Can Patient Liaison Services Transform Clinical Research Access?9/25/2025
Patients often face invisible hurdles in research. Watch how Patient Liaison services can change the journey for participants, sites, and sponsors, making trials easier to join and stay in.
-
Real-Time Trials Need Real-Time Data You Can Trust7/30/2026
The FDA just kicked off real-time clinical trials with AstraZeneca and Amgen. But speed means nothing if the underlying data is inconsistent.
-
Five Preventable Clinical Design Pitfalls And How To Avoid Them7/21/2026
While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.
-
Human Abuse Potential: Selecting A Positive Control5/8/2026
Choosing an effective positive control in HAP studies is critical but not always straightforward. Learn how to justify comparator and dose selection.
-
Bringing Clinical Trials To Everyone's Backyard1/10/2025
Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
-
Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.
View the complete resource library.
Contact an Altasciences expert to learn more about their comprehensive clinical solution.
-
Expert Support for Clinical Research and Research Administration
-
Accelerate trial timelines and recruitment while reducing site burden through this site network solution.
-
Eliminate manual friction and improve trial visibility with pre-configured, validated workflows. Standardize execution and ensure audit-ready data protection across every global site.